204 related articles for article (PubMed ID: 32591615)
21. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
Zhao X; Chen GQ; Cao GM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.
Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q
J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968
[TBL] [Abstract][Full Text] [Related]
23. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM
Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645
[TBL] [Abstract][Full Text] [Related]
24. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
[TBL] [Abstract][Full Text] [Related]
25. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism.
Li W; Shen S; Wu S; Chen Z; Hu C; Yan R
Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.
Ye J; Yao Y; Song Q; Li S; Hu Z; Yu Y; Hu C; Da X; Li H; Chen Q; Wang QK
Sci Rep; 2016 Oct; 6():34034. PubMed ID: 27698442
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.
Hu J; Ruan J; Liu X; Xiao C; Xiong J
Pathol Res Pract; 2018 Dec; 214(12):2039-2045. PubMed ID: 30322806
[TBL] [Abstract][Full Text] [Related]
28. Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.
Wu XG; Zhou CF; Zhang YM; Yan RM; Wei WF; Chen XJ; Yi HY; Liang LJ; Fan LS; Liang L; Wu S; Wang W
Angiogenesis; 2019 Aug; 22(3):397-410. PubMed ID: 30993566
[TBL] [Abstract][Full Text] [Related]
29. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
[TBL] [Abstract][Full Text] [Related]
30. miR-200b-3p/ERG/PTHrP axis mediates the inhibitory effect of ethanol on the differentiation of fetal cartilage into articular cartilage.
Ni Q; Chen H; Li B; He H; Shi H; Zhu J; Wang H; Chen L
Chem Biol Interact; 2022 Dec; 368():110201. PubMed ID: 36174738
[TBL] [Abstract][Full Text] [Related]
31. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.
Li JM; Zhou J; Xu Z; Huang HJ; Chen MJ; Ji JS
J Cell Biochem; 2018 Jul; 119(7):5143-5152. PubMed ID: 29143999
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
[TBL] [Abstract][Full Text] [Related]
34. MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression.
Zhu K; Pan Q; Zhang X; Kong LQ; Fan J; Dai Z; Wang L; Yang XR; Hu J; Wan JL; Zhao YM; Tao ZH; Chai ZT; Zeng HY; Tang ZY; Sun HC; Zhou J
Carcinogenesis; 2013 Sep; 34(9):2071-9. PubMed ID: 23671131
[TBL] [Abstract][Full Text] [Related]
35. Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma.
Tang J; Li Y; Liu K; Zhu Q; Yang WH; Xiong LK; Guo DL
Minerva Med; 2018 Feb; 109(1):15-23. PubMed ID: 28750499
[TBL] [Abstract][Full Text] [Related]
36. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
[TBL] [Abstract][Full Text] [Related]
37. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
38. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway.
Li X; Cheng T; He Y; Zhou S; Wang Y; Zhang K; Yu P
Life Sci; 2019 Sep; 232():116602. PubMed ID: 31251997
[TBL] [Abstract][Full Text] [Related]
39. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma.
Shen H; Li W; Tian Y; Xu P; Wang H; Zhang J; Li Y
J Cell Biochem; 2015 Aug; 116(8):1563-73. PubMed ID: 25649327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]